Australian biotech company Starpharma announces positive inter...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
MELBOURNE, Australia, Nov. 26, 2021 /PRNewswire-AsiaNet/ -- Starpharma showed that 100% of evaluable patients with Stage IV prostate cancer have had efficacy responses, utilising one or more standard measures of disease.DEP(R) cabazitaxel(https://starpharma.com/drug_delivery/dep_cabazitaxel)is a patent...
Authors: LATEST ASIANET NEWS RELEASES